Fast Metabolic Response to Drug Intervention Through Analysis on a Miniaturized, Highly Integrated Molecular Imaging System by Wang, Jun et al.
 
THE JOURNAL OF NUCLEAR MEDICINE • Vol. 54 • No. 10 • October 2013  Wang et al. 
Supplemental Materials and Methods 
RIMChip Design Concepts The RIMChip design has 5 microchannels for executing 5 distinct 
assay conditions. Each microchannel has 4 cell capture chambers in which the assays are 
executed, and so a single assay condition is repeated 4 times. Several key features are designed 
into each microchannel to facilitate processes such as imaging, cell loading, and reagent flushing 
and delivery. First, given the distance and intervening material between the fluidic layer and the 
beta sensing volume, the spatial resolution of the beta camera is 600 µm, and so the nearest 
edges of neighboring microchambers are separated by ~800 µm to avoid signal overlap 
(Supplemental Fig. 1). Second, the microchannels are designed so that cells are captured only 
within the cell capture chambers. Each chamber contains a 7 × 3 waffle-structured array of 200-
m-deep microwells, separated by 30-µm-thick walls. This structure is designed to minimize the 
shear stress exerted onto cells that are attached to the bottom of microwells when flushing 
through new medium or reagents. This waffle design also helps maintain the rigidity of the 
bottom surface. Third, this bottom surface is only 50 m thick because of the constraint that the 
assay sensitivity depends on the proximity of the cells to the camera. This thin-floored PDMS 
chip provides an ~10-fold increase in collected signal over a common glass microscope 
coverslip. It also means that if a cell is trapped outside the cell capture chamber, that cell will 
contribute negligible (<3% of the total counts) signal during an assay, since those cells have up 
to 1 mm of PDMS separating them and the beta camera. Fourth, the microchannel inlet is 
designed to avoid clogging of the channels by bubbles, clumps of cells, or other debris. It is also 
designed for ease of use. The microchannel inlets accommodate a 20- to 200-L pipette tip so 
that standard microwell procedures may be used for the introduction of cells and reagents. The 
bubble depletion chamber (Fig. 1) has a volume of 0.95 µL and successfully removes any 
bubbles that are introduced in the micropipetting steps. The bubble depletion volume is followed 
by a filtering area of posts that have a tailored depth of between 25 and 35 µm. This dimension is 
customized for specific cell types. In this study, we designed a 32-µm gap for liposarcoma cell 
lines and the U87 isogenic cell lines and a 20-µm gap for all suspended cells (which are smaller). 
The filter design also significantly enhances the hydrodynamic resistance of a channel and 
prevents backflow at the completion of solution injection. This significantly increases cell 
loading uniformity. The volumes at the microchannel exits have a size sufficient to hold all the 
overflow from a given micropipetting step. That overflow is removed also using a micropipette. 
The region of the RIMChip containing the cell capture chambers has a 1 × 1 cm footprint for 
matching to the beta-particle camera. 
RIMChip Fabrication The microchip is fabricated from 2 layers of the air-permeable 
elastomer polydimethylsiloxane (PDMS) using standard soft lithography methods. Referring to 
Supplemental Figure 1, the bottom PDMS layer contains the waffle-structured floor and 
sidewalls of the cell capture chambers. This layer is molded from a silicon wafer–based master. 
The features on this master were patterned using photolithography of the negative photoresist 
SU8 2025 (Microchem). The height of these features is about 50 µm. The top PDMS layer 
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contains all other features (Supplemental Fig. 1). The mold used to form this top PDMS layer 
was fabricated differently. We first patterned the filter layer using SU8 2025 with a height of 25 
µm and then patterned the second layer of microchannels and cell capture chambers using SU8 
2100 (Microchem) on the same wafer. The second patterned layer has a height of 200 µm. This 
is to ensure that the volume of the cell capture chambers has sufficient nutrients to support 
captured cells for the duration of the on-chip culturing steps that are required as a part of the 
Betabox assays. 
A precured PDMS mixture with a ratio of 5:1 (precursor to cross-linker) is used to fabricate the 
top PDMS replica, and 20:1 is used for bottom PDMS replica. After curing both PDMS replicas, 
we trimmed and punched the top PDMS layer with appropriate inlet and outlet holes at 1.5-mm 
and 5-mm diameters, respectively, and then aligned and mated the top and bottom PDMS layers. 
Subsequently, the whole assembly was baked at 80°C overnight to seal those layers together. 
Finally, the entire microchannel was filled with PBS solution through dead-end filling by 
exerting 3 psi N2 pressure in a tubing connected to the microchip. 
The beta-particle camera (Betabox). The imaging system is a direct detection beta particle 
detection camera utilizing a 13.5  13.5 mm2 active area position-sensitive avalanche photodiode 
(PSAPD) (Radiation Monitoring Devices). The 5 outputs of the PSAPD first pass through CR-
110 charge-sensitive preamplifiers and then shaping amplifiers with a 200-ns shaping time. The 
shaped sum signal then passes to a threshold comparator that produces event trigger pulses to 4 
sample and hold (S/H) circuits (53-ns acquisition time, 6-s hold time). These circuits then 
initiate an analog-to-digital conversion of the positioning channels using a simultaneous 
sampling data acquisition system (DAQ) (National Instruments PCI-6143). Beta distribution 
images were created using the algorithm proposed by Zhang (1). 
Surface coating. For adherent cell lines, the microchamber surface was coated with various 
substrates to test cell adhesion. Fibronectin (BD Biosciences) was used to coat the PDMS 
microchannel and cell capture chamber surfaces at a variety of concentrations of 1, 0.5, 0.33, and 
0.25 mg/mL. Those surfactant solutions were injected into microchannels by pressing a pipette 
for 30 s and then incubating the RIMChip at least overnight before use. Liposarcoma cells were 
then loaded into each of the microchannels, and the microchip was incubated in a cell incubator 
at 37°C for 4 h. Microscopic examination of the trapped cells did not reveal any differences in 
terms of cell attachment and cell number distributions for these various treatment chemistries. 
We then executed 18F-FDG Betabox radioassays to investigate whether the various surface-
coating conditions influenced glucose metabolism of the captured cells. The result, shown in 
Supplemental Figure 3A, indicated that the fibronectin coating chemistry also did not 
significantly influence the radioassay. 
We also investigated the influence of incubation time on radioassays for the fibronectin coating. 
Four microchannels were incubated with 0.25 mg/mL fibronectin in PBS for 1, 2, 3, and 4 d 
under ambient conditions. Cells were loaded into the 4 microchannels and processed as described 
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above. Again, we did not observe differences in terms of cell attachment and cell number 
distribution (Supplemental Fig. 3B), except in the microchannel without the fibronectin 
treatment. The cells within the uncoated chambers did not appear adherent and spread out, 
relative to those cells in the fibronectin-coated chambers. However, the attachment apparently 
did not significantly influence the radioassay result. 
Cell-loading statistics. Various cell lines were tested in the RIMChip. Adherent cell lines 
included liposarcoma LS030609 and its MCT-1 deficient line, liposarcoma 060208 and its dCK 
knockdown line, and the glioblastoma U87 EGFRvIII PTEN cells. Nonadherent cell lines were 
murine leukemic lines L1210 and its dCK knockdown line, and the Jurkat T cell line. LS060208 
liposarcoma cells showed uniform cell number loading along a channel and across the 4 
chambers within a channel (Supplemental Fig. 2). A 9.8%–16.9% variation between the 4 cell 
capture chambers within 1 microchannel, and 6.5% cell number difference across all 
microchannels on a RIMChip, was observed when 50–60 cells were loaded per chamber.  
Suspension cells attached to the hydrophobic PDMS surface without any coating. Up to 4 h of 
incubation of L1210 leukemia cells, CEM cells, and Jurkat T cells (all suspension cells) did not 
result in loss of cell number (Supplemental Figs. 4A and 4B) or viability, indicating that the 
surface attachment is robust and not cell type–specific. However, the uniformity of the deposited 
cell distribution is susceptible to the hydrodynamic resistance encountered by the cell suspension 
as it flows through the channel. This may be minimized by optimizing the inlet filter gap (Fig. 
1A). A filter gap of 20 µm was used for studying all the (relatively small) suspension cells, and 
this improved loading uniformity. 
RIMChip radioassay execution. Each RIMChip assay relies on the use of a pipette for all fluidic 
control. To replace a solution in microchannels, a new solution is introduced through the 
microchannel inlets. Excess solution is removed at the outlets using a 100-L pipette. For 
adherent cells, the RIMChip was prepared with a fibronectin surface coating. Immediately before 
cell loading, the outlets were drained of solution. Cells at a concentration of 3 × 106/mL were 
injected into the microchip from inlets by pressing a pipette for 5 s, which is sufficient to cover 
all microchannels with cells. The outlets were then refilled with cell culture medium to prevent 
the connected microchannels from drying out during the incubation period. The RIMChip was 
then placed into a CO2 incubator at 37°C with 100% humidity for 4 h. After incubation, the 
microchannels were flushed 2 times with flowing ~20 L PBS, by pressing a pipette for 30 s, to 
flush out any residual glucose. About 10 L 1 mCi/mL 18F-FDG or 0.01 mCi/mL 18F-FAC in 
PBS was loaded into the microchannels by pressing the pipette for 15 s. The whole microchip 
was then incubated for 30 min in a CO2 incubator at 37°C. It was the flushed 2 times with 
flowing ~20 L PBS. The RIMChip was then ready for mounting onto the beta camera. 
For drug inhibition studies, we introduced the cells onto the RIMChip 4 h before the radioassay. 
5 mM 2-deoxyglucose (2DG), 10 µM gemcitabine, or 5 M erlotinib in RPMI 1640 or DMEM 
medium supplemented with 10% FBS was then added to the microchannels by pipetting, and 
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incubated with cells for designated periods. Drug molecules were removed from the 
microchannels by PBS flushing twice. Immediately following, 1 mCi activity of 18F-FDG in PBS 
was introduced into the microchambers. Adjacent microchannels were devoted to assay/control 
pairs, with the control microchannel treated equally to the assay microchannel, except that no 
drug was added. The signal averaged from the 4 cell capture microchambers within the control 
microchannel was converted into activity per cell and then used for normalization of the 
similarly converted signal from the drug-treated cells. 
The imaging acquisition time depends on the activity of radioactive probe used for the 
radioassay, with other experimental conditions set. We used 1 mCi/mL activity of 18F-FDG for 
tests on both adherent and suspended cells, with a fixed incubation time of 30 min. The imaging 
acquisition time was set to 5 min. We also explored lowering the dosage of 18F-FAC to 10 
Ci/mL for suspended cells and used an acquisition time of 10 min. Even with such low activity, 
the RIMChip platform still differentiated the leukemic line L1210 from its dCK knockdown line. 
Off-chip radioassay. In parallel with on-chip radioassay, off-chip radioassays were performed 
for each cell sample. Liposarcoma cells were detached from a Petri dish and transferred to a 12-
well plate, with each well containing ~104 cells. The poly-D-lysine–coated plates were then 
placed in a CO2 incubator at 37°C for 4 h to allow for cell attachment to well plate bottom. Ten 
microcuries of 18F-FDG or 18F-FAC was added to each well, followed by 30-min incubation. 
Each well was then flushed 2 times with PBS. The cells were then lysed, and the cell lysates 
were transferred to plastic vials. The radioactivity of each cell sample was measured using a 
well-type γ-counter (1480 Wizard 3; Perkin Elmer). 
Data processing. The radio-image was segmented into 20 rectangular regions of interest (ROIs), 
each of which overlaps a cell chamber and contains the beta particle counts from that cell 
chamber. The size of ROIs has been optimized by separate experiments to contain >95% of the 
beta particle counts from a cell chamber and <5% from neighbor chambers. Beta particle counts 
of each ROI were quantitated by a custom-written Matlab program. The background level was 
defined from the averaged beta particle counts from 4 ROIs that covered the 4 cell capture 
chambers in a microchannel that contained zero cells. For facilitation of cell counting using a 
fluorescence microscope, we stained cells with nuclear dye Hoechst 33342. A script written in 
ImageJ was used to automate cell counting. The radioactivity of each ROI was normalized by its 
cell number, and statistics for a given assay condition were calculated from the 4 repeat assays 
within a given microchannel. We limited comparisons of absolute beta particle counting results 
across different experimental conditions to only those assays that were executed simultaneously 
and on the same RIMChip. To compare the results across different RIMChips, we selected 1 of 
the 5 microchannels from each RIMChip as a reference, and repeated the same experiment 
across all RIMChips that were to be compared. The radioactivity of the other microchannels was 
then normalized to the reference microchannel (Figs. 3A and 3B). This meant that it was not 
necessary to account for the changing radioactivity from the 18F-labeled radiopharmaceutical 
imaging probe. 
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SUPPLEMENTAL FIGURE 1. Fabrication of the RIMChip. The bottom and top 
polydimethylsilane (PDMS) layers are separately fabricated and then sealed together. Each layer 
is formed using a mold to shape the curing PDMS. The bottom PDMS layer is molded using a 
patterned silicon master. The top PDMS layer is molded using a master that is comprised of a 
patterned multilayer master. Multiple layers of this master are required to generate all of the 
features of this top PDMS layer. The top PDMS layer contains most of features of a final 
RIMChip, except walls and waffle-structured floors of the cell capture chambers, which are 
contained within the bottom PDMS layer. 
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SUPPLEMENTAL FIGURE 2. Distribution of adherent (liposarcoma) cells within fibronectin-
coated cell capture microchambers. Each bar in the bar graph represents the averaged cell 
loading results within the 4 separate microchambers that comprise a single channel. Microscopy 
images of the capture cells (not shown) reveal that the liposarcoma cells were surface-adherent 
after 4 h of incubation. Nuclear (fluorescent) staining facilitates cell number counting by 
fluorescence microscopy and automated counting algorithms. 
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SUPPLEMENTAL FIGURE 3. Effect of fibronectin coating on 18F-FDG uptake by 
liposarcoma cells. (a) Effect of fibronectin concentration for coating on uptake of 18F-FDG. The 
initial concentration is 0.25 mg/mL, which is diluted 2 times, 3 times, and 4 times. Cells do not 
demonstrate a significant difference with respect to 18F-FDG uptake except in the cell chambers 
coated with the highest concentration of fibronectin. (b) Channels 1, 2, 3, and 4 were coated with 
fibronectin for 4, 3, 2, and 1 days, respectively. Channel 5 was not coated. Then, cells were 
loaded into the cell capture chambers and incubated for 4 h. In channel 5, the cells are not as 
efficiently captured within the cell capture chambers. 18F-FDG was then added according to the 
described protocols. No significant differences in 18F-FDG uptake per cell were observed 
between any of the 5 channels, including the noncoated channel 5, although the cells were 
adherent only in the chambers associated with microchannels 1-4. 
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SUPPLEMENTAL FIGURE 4. Uniformity of cell loading within the cell capture chambers of 
a RIMChip before and after cell incubation and reagent flushing. L1210 lymphoma cells were 
loaded into 4 of the microchannels of a RIMChip and incubated in RPMI 1640 medium 
supplemented with 10% FBS for 1 h. The microchannels were then flushed with the various 
reagents (except a radioimaging probe) to simulate an actual radioassay. Cell number per cell 
capture microchamber, as well as their positions within the chambers, was recorded before and 
after the various reagent introductions and flushing steps. As shown for both (a) L1210 cells and 
(b) Jurkat cells, the various assay steps did not physically influence the cell loading. 
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SUPPLEMENTAL FIGURE 5. Proliferation assay on (a) L1210-wt and (b) L1210-10k cells, 
as measured by flow cytometry. Each cell sample was treated with 10 µM gemcitabine for the 
indicated durations. The spike at the right of the histograms represents cells in the G2/M phase, 
and the spike at the left represents the G0 phase. 
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SUPPLEMENTAL FIGURE 6. Quantification of the percentage of cells in the G2/M phase 
when L1210-wt L1210-10K cells were treated with 10 mM gemcitabine for the designated 
durations. 
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SUPPLEMENTAL FIGURE 7. The kinetics of 18F-FDG uptake, and of the levels of various 
assayed proteins, as a function of 5 mM erlotinib treatment. The y-axis of these plots reflect the 
percentage levels relative to 100% at time = 0. Error bars indicate fluctuations of 3 repeats. 
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SUPPLEMENTAL FIGURE 8. Kinetics plot, showing the percentage of cells in S and G2/M 
phases of the cell cycle for U87 EGFR vIII/PTEN cells that were treated with 5 mM erlotinib for 
the designated durations. 
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SUPPLEMENTAL TABLE 1. List of Antibodies Used for 
Protein Assays from the U87 EGFRvIII PTEN Cells 
DNA label Antibody (ventor: clone) Source 
D 
mouse anti-hu phospho-EGFR R&D Y1068 
biotin-labeled goat anti-hu EGFR R&D BAF231 
E anti-hu phospho-Ampka kit R&D DYC 3528 
F anti-hu p53 kit R&D DYC 1746 
G anti-hu Bcl2 kit R&D DYC 827B 
I anti-hu phospho-mTOR kit R&D DYC 1665 
K anti-hu phoshpo-ERK kit R&D DYC 1018B 
L anti-hu phospho-Akt1 kit R&D DYC 2289 
 
